WO2014087422A1 - Chewable milk compositions and fortified powder formulations thereof - Google Patents
Chewable milk compositions and fortified powder formulations thereof Download PDFInfo
- Publication number
- WO2014087422A1 WO2014087422A1 PCT/IN2013/000737 IN2013000737W WO2014087422A1 WO 2014087422 A1 WO2014087422 A1 WO 2014087422A1 IN 2013000737 W IN2013000737 W IN 2013000737W WO 2014087422 A1 WO2014087422 A1 WO 2014087422A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- milk
- dosage form
- essentially
- solid dosage
- powder
- Prior art date
Links
- 239000008267 milk Substances 0.000 title claims abstract description 213
- 210000004080 milk Anatomy 0.000 title claims abstract description 213
- 235000013336 milk Nutrition 0.000 title claims abstract description 212
- 239000000843 powder Substances 0.000 title claims abstract description 97
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 238000009472 formulation Methods 0.000 title claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims abstract description 37
- 239000007909 solid dosage form Substances 0.000 claims abstract description 35
- 239000007910 chewable tablet Substances 0.000 claims abstract description 31
- 230000008569 process Effects 0.000 claims abstract description 30
- 235000013305 food Nutrition 0.000 claims abstract description 27
- 239000004615 ingredient Substances 0.000 claims abstract description 27
- 229940068682 chewable tablet Drugs 0.000 claims abstract description 23
- 239000011230 binding agent Substances 0.000 claims abstract description 22
- 238000005469 granulation Methods 0.000 claims abstract description 11
- 230000003179 granulation Effects 0.000 claims abstract description 11
- 240000007594 Oryza sativa Species 0.000 claims abstract description 10
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 10
- 235000013312 flour Nutrition 0.000 claims abstract description 10
- 235000009566 rice Nutrition 0.000 claims abstract description 10
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 7
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 7
- 235000005911 diet Nutrition 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 7
- 235000013345 egg yolk Nutrition 0.000 claims abstract description 7
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 7
- 230000037213 diet Effects 0.000 claims abstract description 6
- 238000003825 pressing Methods 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims description 39
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 30
- 239000000796 flavoring agent Substances 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 28
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 25
- 235000000346 sugar Nutrition 0.000 claims description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 22
- 235000015097 nutrients Nutrition 0.000 claims description 21
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 18
- 239000004376 Sucralose Substances 0.000 claims description 16
- 235000019408 sucralose Nutrition 0.000 claims description 16
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 16
- 229940088594 vitamin Drugs 0.000 claims description 16
- 229930003231 vitamin Natural products 0.000 claims description 16
- 235000013343 vitamin Nutrition 0.000 claims description 16
- 239000011782 vitamin Substances 0.000 claims description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 15
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 15
- 229960000304 folic acid Drugs 0.000 claims description 15
- 235000019152 folic acid Nutrition 0.000 claims description 15
- 239000011724 folic acid Substances 0.000 claims description 15
- 235000013355 food flavoring agent Nutrition 0.000 claims description 15
- 235000003599 food sweetener Nutrition 0.000 claims description 15
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 15
- 235000010755 mineral Nutrition 0.000 claims description 15
- 239000011707 mineral Substances 0.000 claims description 15
- 238000012856 packing Methods 0.000 claims description 15
- 239000003765 sweetening agent Substances 0.000 claims description 15
- 238000009480 moisture-activated dry granulation Methods 0.000 claims description 14
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 14
- 235000019634 flavors Nutrition 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 13
- 239000011647 vitamin D3 Substances 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 12
- 235000005282 vitamin D3 Nutrition 0.000 claims description 12
- 229940021056 vitamin d3 Drugs 0.000 claims description 12
- 235000008939 whole milk Nutrition 0.000 claims description 12
- 229910052742 iron Inorganic materials 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 10
- 239000003937 drug carrier Substances 0.000 claims description 10
- 239000012943 hotmelt Substances 0.000 claims description 10
- 235000020183 skimmed milk Nutrition 0.000 claims description 10
- 239000011701 zinc Substances 0.000 claims description 10
- 229910052725 zinc Inorganic materials 0.000 claims description 10
- 238000009826 distribution Methods 0.000 claims description 9
- 235000019359 magnesium stearate Nutrition 0.000 claims description 9
- 238000007909 melt granulation Methods 0.000 claims description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 9
- 239000000454 talc Substances 0.000 claims description 9
- 229910052623 talc Inorganic materials 0.000 claims description 9
- 235000012222 talc Nutrition 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 8
- -1 gyceryl monostearate Natural products 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 238000005550 wet granulation Methods 0.000 claims description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 7
- 239000011790 ferrous sulphate Substances 0.000 claims description 7
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 7
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 7
- 238000003801 milling Methods 0.000 claims description 7
- 239000006041 probiotic Substances 0.000 claims description 7
- 235000018291 probiotics Nutrition 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 102000014171 Milk Proteins Human genes 0.000 claims description 6
- 108010011756 Milk Proteins Proteins 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 235000001465 calcium Nutrition 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 6
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 239000000391 magnesium silicate Substances 0.000 claims description 6
- 229940099273 magnesium trisilicate Drugs 0.000 claims description 6
- 229910000386 magnesium trisilicate Inorganic materials 0.000 claims description 6
- 235000019793 magnesium trisilicate Nutrition 0.000 claims description 6
- 235000021239 milk protein Nutrition 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 229940069328 povidone Drugs 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 235000013373 food additive Nutrition 0.000 claims description 5
- 239000002778 food additive Substances 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims description 4
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 4
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 4
- 239000004384 Neotame Substances 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000013871 bee wax Nutrition 0.000 claims description 4
- 229940092738 beeswax Drugs 0.000 claims description 4
- 239000012166 beeswax Substances 0.000 claims description 4
- 235000015895 biscuits Nutrition 0.000 claims description 4
- 239000004203 carnauba wax Substances 0.000 claims description 4
- 235000013869 carnauba wax Nutrition 0.000 claims description 4
- 229940082483 carnauba wax Drugs 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 4
- 229940074979 cetyl palmitate Drugs 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- 229940049654 glyceryl behenate Drugs 0.000 claims description 4
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 4
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 4
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 235000019412 neotame Nutrition 0.000 claims description 4
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 4
- 108010070257 neotame Proteins 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 239000012188 paraffin wax Substances 0.000 claims description 4
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- 229960000541 cetyl alcohol Drugs 0.000 claims description 3
- 210000003022 colostrum Anatomy 0.000 claims description 3
- 235000021277 colostrum Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229940068984 polyvinyl alcohol Drugs 0.000 claims description 3
- 235000008160 pyridoxine Nutrition 0.000 claims description 3
- 239000011677 pyridoxine Substances 0.000 claims description 3
- 229940098524 pyridoxine 1 mg Drugs 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 229940032147 starch Drugs 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 230000007423 decrease Effects 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 2
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000005063 solubilization Methods 0.000 claims description 2
- 230000007928 solubilization Effects 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 235000019809 paraffin wax Nutrition 0.000 claims 2
- 235000019271 petrolatum Nutrition 0.000 claims 2
- 240000009122 Satureja thymbra Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 235000008476 powdered milk Nutrition 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 description 15
- 239000007787 solid Substances 0.000 description 14
- 230000035764 nutrition Effects 0.000 description 13
- 235000010216 calcium carbonate Nutrition 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000007906 compression Methods 0.000 description 7
- 230000006835 compression Effects 0.000 description 7
- 244000269722 Thea sinensis Species 0.000 description 6
- 235000016213 coffee Nutrition 0.000 description 6
- 235000013353 coffee beverage Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000020774 essential nutrients Nutrition 0.000 description 6
- 235000013616 tea Nutrition 0.000 description 6
- 238000007580 dry-mixing Methods 0.000 description 5
- 239000007892 solid unit dosage form Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 235000021196 dietary intervention Nutrition 0.000 description 4
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 4
- 239000004174 erythrosine Substances 0.000 description 4
- 235000012732 erythrosine Nutrition 0.000 description 4
- 229940011411 erythrosine Drugs 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000020186 condensed milk Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- XBDUTCVQJHJTQZ-UHFFFAOYSA-L iron(2+) sulfate monohydrate Chemical compound O.[Fe+2].[O-]S([O-])(=O)=O XBDUTCVQJHJTQZ-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000020124 milk-based beverage Nutrition 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 244000269261 Alocasia Species 0.000 description 1
- 240000004161 Artocarpus altilis Species 0.000 description 1
- 235000002672 Artocarpus altilis Nutrition 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- 235000000378 Caryota urens Nutrition 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 240000000163 Cycas revoluta Species 0.000 description 1
- 235000008601 Cycas revoluta Nutrition 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 244000060474 Eugenia jambolana Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000010103 Metroxylon rumphii Nutrition 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000020243 first infant milk formula Nutrition 0.000 description 1
- 235000019541 flavored milk drink Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 235000020189 fortified milk Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012776 robust process Methods 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/18—Milk in dried and compressed or semi-solid form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/154—Milk preparations; Milk powder or milk powder preparations containing additives containing thickening substances, eggs or cereal preparations; Milk gels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
Definitions
- Milk has been considered as very important source of nutrition, since time immemorial. During the early years of growth milk constitutes the major part of diet. In many countries milk is supplied by government or nonprofit organization to school, so that health of the school children can be taken care of. But milk itself has many limitations that creates hurdle in its storage, supply and distribution. Milk has short shelf life hence its stability is poor. Milk requires significantly large storage space and refrigeration and thus it is often difficult to transport or store in its liquid form due to the weight and its highly perishable nature. The physical delivery of milk to schools, dairy and distributors requires stocking milk in refrigerators. And, schools are also required to have the provision for refrigerators/ chilled vending for storage of fresh milk. All these practices increase the cost of milk distribution.
- Milk in liquid form that is supplied to nutrition intervention programs or applied nutrition programs is also very much prone for adulteration and its unauthorized clandestine diversion for unintended uses such as for drinking or for usual milk applications such as making tea, coffee, sweets, yogurts, cheese etc.
- This pilferage or/and wastage/ or spoilage of liquid milk in a school feeding program is a great practical problem difficult to solve.
- Convenient distribution of liquid milk amongst the beneficiaries every day is also very difficult to manage.
- Unauthorized use mentioned above includes use for household purposes or for commercial purposes to make milk containing beverages like tea/coffee, or milk containing sweets etc.
- liquid milk is prone for pilferage.
- Liquid milk is highly susceptible to microbial growth on storage. Milk contains most of the nutrients that are required for the growth of children but many children do not like taste of liquid milk. In case of liquid milk, continuous periodic testing and vigilance is required for maintaining its quality. This testing and vigilance require infrastructure which is difficult to maintain and create. Lack of testing and vigilance affect viability of distribution of liquid milk in Nutrition Intervention programs or applied Nutrition programs seriously.
- This invention was based on the knowledge that solid milk with sufficient solubility and strength can be obtained basically by compacting and molding only powdered milk as an ingredient under a condition where porosity and free fat content thereof are controlled within fixed ranges and then humidifying and drying. This, however, needs to be reconstituted with water by weighing known quantity of solid milk and b adding water to it.
- Henry Secher Brochner (GB894001 A ) formulated milk tablets readily soluble in coffee and tea. It contained 10-19 %butter fat, 7-15% milk protein, 15-65% milk carbohydrates and minor amounts of inorganic milk constituents and water, and is enriched with respect to one or more of the butter fat, protein or carbohydrate.
- condensed milk was evaporated to at least 6% of fat content to powder, and powder was mixed with milk proteins and lactose in requisite proportion. But being readily soluble in coffee and tea makes it pilferage prone and unsuitable for a Nutritional Intervention program since the product cannot be prevented from use for an unauthorized / un-intended purposes.
- This invention comprises a solid dosage form of milk that is essentially substantially water insoluble in water and does not contain rice flour or any other staple food source that is used as food in daily diet by a human being or dried egg yolk powder.
- the milk powder includes one or more of, without limitation, whole milk powder, partly skimmed milk powder, skimmed milk powder, and colostrum powder.
- the solid dosage form of milk comprises milk powder and at least one binder.
- the solid dosage form of milk of this invention further comprising other ingredients also.
- the other ingredients may comprise permitted food additives and permitted pharmaceutical ingredients and excipients.
- the solid dosage form of milk is a chewable tablet or other chewable compressed formulation.
- the chewable tablet of milk comprises a predetermined shape and size.
- the shape and size of the chewable tablet of milk is chosen such that the product is easy to handle during transportation and easier for distribution.
- the chewable tablet of milk may be biscuit shaped.
- the chewable tablet of milk conveniently weights 5.50 g to 7.50 g.
- the chewable tablet of milk powder may comprise an accurate desired dose of all the nutrients corresponding to a certain quantity of liquid whole milk or a milk powder.
- the solid dosage form of milk according to this invention comprises an essentially water insoluble granulated milk powder.
- this invention comprises a process of making a solid dosage form of milk that is essentially substantially water insoluble in water and does not contain rice flour or dried egg yolk powder, or any other staple food source that is used as food in daily diet by a human being, the process comprising steps of: (a) mixing the milk powder with at least one binder and optionally other ingredients; wherein the binder is such that upon binding, the solubility of milk powder in water decreases, (b) granulation, (c) drying and milling the granules, if required, (d) optionally adding flavor, and (e) either (i) packing the resulting an essentially water insoluble granulated milk powder in sachets, or (ii) adding glident s and pressing into chewable
- the step of granulation is either wet granulation, hot melt granulation or moisture activated dry granulation.
- the process of making a solid dosage form of milk of this invention results is an essentially water insoluble granulated milk powder when the final granulated powder resulting form the process is not pressed to result into a chewable tablet or other chewable compressed formulation.
- the process of making a solid dosage form of milk of this invention results into a chewable tablet or other chewable compressed formulation when the final granulated powder is mixed with glidents and pressed.
- this invention comprises a solid unit dosage form of whole milk or skimmed milk, with or without fortification by one or more of essential nutrients, colors, flavors and excipients; wherein the solid unit dosage form cannot be re-constituted as liquid milk.
- the compositions of this invention differ from prior art in that they are formulated to be very close to the composition of whole milk or to the composition of whole milk supplemented with one or more of specific isolates of nutrients. Thus the compositions of this invention cannot have any staple food item such as rice flour or egg yolk or any such staple food items etc. as supplementing / fortifying ingredients in order to avoid significant deviation from the composition of milk.
- staple food sometimes simply referred to as a “staple” is a food, as defined by the link http://en.wikipedia.org/wiki/Staple_food that is eaten routinely and in such quantities that it constitutes a dominant portion of a standard diet in a given population, supplying a large fraction of the needs for energy-rich materials and generally a significant proportion of the intake of other nutrients as well.
- Staple foods vary from place to place, but typically they are inexpensive or readily available foods that supply one or more of the three organic macronutrients needed for survival and health: carbohydrates, proteins, and fats.” Still further, the link notes that "Most staple plant foods are derived either from cereals such as wheat, barley, rye, maize, or rice, or starchy tubers or root vegetables such as potatoes, yams, taro, and cassava. Other staple foods include pulses (dried legumes), sago (derived from the pith of the sago palm tree), and fruits such as breadfruit and plantains. Staple foods may also contain, depending on the region, sorghum, olive oil, coconut oil and sugar. Most staples are plant materials, but in some communities fishing is the primary source of nutrition.”
- Staple food as is used here is intended to exclude nutrients or selective class of nutrients that are in the form of essentially pure isolated compositions made either chemically or from their natural raw material sources.
- wheat flour or corn flour are included in the term “Staple food”
- wheat germ oil or corn oil being nutrients isolated form their raw material
- an antioxidant extracted from its raw material in an isolate form, such as alpha- tocopherol would be excluded form the term “Staple food” or “Staple” and would come in the category of "anti-oxidants” that can be added to the compositions of this invention.
- the invention also comprises a method of making a solid unit dosage form of whole milk or skimmed milk, with or without fortification by one or more of essential nutrients, colours, flavors and excipients; wherein the solid unit dosage form cannot be re-constituted as liquid milk and none of the fortification ingredients are naturally grown and naturally available food items that are consumed traditionally/conventionally.
- the "nutrients”, for the purpose of this specification, are defined to comprise, without limitation, one or more of vitamins, minerals and anti-oxidants and probiotics.
- the probiotics that can be added includes, without limitation, the bacteria Lactobacillus sp. With the changing demographic profile we expect to have more share of elderly people in the population. This set of population has its own set of nutritional requirements. Addition of probiotic in the milk formulations will meet nutritional requirement of geriatric population and menopausal women.
- the unit dosage form of milk of this invention lacks at least one organoleptic property of milk in such a way that the product or its diluted form cannot be used for food applications for which liquid milk or condensed (boiled down or concentrated) milk or milk powder is used in the past.
- the unit dosage form of milk of this invention cannot be used for applications in which liquid milk or condensed milk or milk powder needs to be used for their organoleptic properties.
- the product of this invention cannot either (a) be reconstituted into liquid milk by dissolving in water for making tea, coffee, curd or for drinking, flavored milk or (b) be used for adding in sweets that need liquid milk, condensed milk or a milk powder as an ingredient;
- sweets include, without limitation, Indian recipes Pedha, Gulab Jamun, Barfi, Kala-kand, Ras-gulla etc.
- this invention comprises solid compressed dosage forms of milk.
- Most preferred form is tablets.
- the tablets may be biscuit shaped.
- the compressed form may be other than a tablet also.
- the solid dosage form of milk of this invention further comprises other ingredients also besides milk.
- the ether ingredients may comprise permitted food additives and permitted pharmaceutical ingredients and excipients.
- the food additives and permitted pharmaceutical ingredients and excipients may comprise, without limitation, one or more of nutrients, colours, flavors, pharmaceutically acceptable carriers, sweeteners, antioxidents, other excipients not mentioned here and ingredients.
- the pharmaceutically acceptable carrier may include, without limitation, one or more of lactose, mannitol, dicalcium phosphate, microcrystalline cellulose, dextrose, maltose and the like.
- Sweetener may comprise without limitation, one or more of sucralose, aspartame, neotame, sodium saccharin, potassium acesulfame and sucrose.
- Nutrients may comprises, without limitation, one or more of vitamins proteins .minerals and probiotics and the like. Vitamins added to the composition of this invention may include, without limitation, one or more of thaimine, riboflavin, Instagramnamide, folic acid, pyridoxine, cynocobalamine, vitamin C and Vitamin D and the like.
- the "Vitamin D" includes all of its different forms, including Vitamin D3.
- Minerals may include, without limitation, one or more of iron as ferrous sulfate, calcium as calcium carbonate, zinc as zinc sulpahte and magnesium as magnesium trisilicate and the like,
- a recommended unit dose of the solid dosage form of milk of this invention may range from 5.5 gram to 7.5 gram.
- the solid dosage form of milk according to this invention may have, per unit dose that weights 5.50 g to 7.50 g: (a) vitamins added to it, essentially comprising thaimine 1 to 4.5 mg, riboflavin 1 to 5 mg, Georgianamide 1 to 40 mg, folic acid 100 meg to 500 meg, pyridoxine 1 mg to 3 mg, cynocobalamine 1 to 5 meg, vitamin C 30 mg to 80 mg, Vitamin D3 100 IU to 400 IU; (b) minerals added to it essentially comprising 10 to 200 mg of calcium as calcium carbonate, 2- to 10 mg of zinc as zinc sulpahte and 25 to 100 mg of magnesium as magnesium trisilicate, 5 to 525 mg of ferrous sulfate, (c) sweeteners added to it essentially comprising essentially of 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg of sugar, 1.0 mg to 50.0 mg of aspartame, 0.5 mg to 5 mg of neot
- the solid dosage form of milk may contain supplement of (a) the mineral in the form of enteric release iron, (b) one or more of the vitamin selected from the group consisting of folic acid and Vitamin D3, and (c) the protein as milk protein.
- an illustrative chewable tablet of milk may comprise Iron consisting essentially of 5 to 575 mg ferrous as ferrous sulphate, 100 meg to 500 meg of Folic acid, 1 mg to 100 mg of sweetener, 0.1.0 mg to 10.0 mg of flavoring agents and a pharmaceutically acceptable carrier, wherein the complete dosage unit weighting 5.50 g to 7.50 g.
- Another illustrative chewable tablet of milk according to this invention may comprise Vitamin D3 essentially 100 IU to 400 IU, Calcium carbonate essentially 10 mg to 200 mg, sweetener 1.0 mg to 100.0, and flavoring agents 0.11 to 10 mg and weighing round 5.50 g to 7.50 g.
- the chewable tablet of milk according to this invention may comprise the sweetener 1.0 mg to 10.0 mg of sucralose and/or 10.0 mg to 100.0 mg sugar,
- this invention comprises a chewable milk tablet or an essentially water insoluble milk powder, that does not reconstitute into liquid milk on adding water to the same.
- the chewable milk tablet is made in predetermined shape and size.
- the shape and size is chosen such that the product is easy to handle during transportation and hence easier for distribution and does not have the disadvantage of large storage space and refrigeration required for use of liquid milk for nutritional intervention programs.
- the chewable milk tablet is made to provide an accurate desired dose of all the nutrients corresponding to a certain quantity of liquid milk or a milk powder.
- the chewable milk tablet or the water insoluble milk powder is fortified with essential nutrients that can be added in an accurate and desired quantity in each tablet.
- the said essential nutrients may, without limitation, be one or more of vitamins, minerals. This will overcome the need of additional vitamins and minerals supplements that are usually required to be given separately to the beneficiaries of Applied Nutrition Programs such as for school children, women and elderly population.
- a method of making a solid unit dosage form of whole milk or skimmed milk of this invention comprises granulation for developing solid compressed milk formulation without the use of water or with use of a quantity of water that does not give a scope for microbial growth in the dosage form.
- milk based formulations of this invention are made with the use of different colors and flavors to make them children friendly.
- This invention comprises a milk based formulation with standardized composition prepared on large scale that cannot be adulterated and requires no further analysis at various locations once produced and packaged.
- Invention is also embodied wherein the compressed milk tablets are fortified with probiotics that offer several health benefits.
- milk powder means and includes any one selected from the group of whole milk powder, skimmed milk powder, partly skimmed milk powder or colostrum powder. Perishability of milk was overcome by using solid milk powder instead of liquid milk, thus resulting in chewable milk tablets with greater shelf life.
- the present invention also comprises a unique composition of chewable milk tablets and method of manufacturing thereof.
- the essentially sunstantial reduction of the milk powder in water is achieved by use of binders, the binder being a food additive that shall bind the particles of the milk powder composition together when bound with ingredients of the milk powder and shall essentially retard or prevent solubilization/dissolution of the components held by it when contacted with water.
- the binder being a food additive that shall bind the particles of the milk powder composition together when bound with ingredients of the milk powder and shall essentially retard or prevent solubilization/dissolution of the components held by it when contacted with water.
- the binder comprises, one or more, without limitation, povidone, starch, maltodextrin, polyvinyl alcohol, xanthan gum, Sugar esters, gelucire, polyethylene glycols, stearic acid, cetyl alcohol, carnauba wax, paraffin wax, cetostearyl alcohol, hydrogenated castor oil, gyceryl monostearate, xylitol, pearlitol, beeswax, cetyl palmitate, glyceryl behenate, and the like.
- this invention comprises use of wet granulation for making milk tablets. It is also another embodiment of this invention wherein Hot Melt Granulation is used for making milk tablets. It is still another embodiment of this invention wherein Moisture Activated Dry Granulation (MADG) is used to make milk tablets.
- MADG Moisture Activated Dry Granulation
- this invention comprises a process of manufacturing of the compressed milk wherein in the drying process and sifting is avoided by using moisture activated/aided dry granulation process.
- the MADG method produces granules with excellent flow-ability.
- MADG is a simple, economical, clean, lean and robust process that creates granulation with very good physical properties and finished products with satisfactory quality attributes.
- MADG process only a small amount of water is used to create agglomeration. Moisture distribution and absorption steps follow, and neither heat drying nor milling is needed.
- Hot Melt Granulation drying step can be avoided, and hence it is time saving, cost effective and economic process.
- solid milk chewable tablets are provided without any addition of external moisture and method of manufacturing thereof.
- the method of manufacture uses Hot Melt Granulation process. In this embodiment, this was achieved by using binders that melt at higher temperature and bring about granulation upon cooling.
- the hot melt binders that can be used in present invention include, without limitation, one or more of or a mixture of one or more of polyethylene glycol 6000, polyethylene glycol 4000, carnauba wax, stearic acid, sugar esters, cetostearyl alcohol, hydrogenated castor oil, gelucire 55/18, gelucire 50/02, glyceryl monostearate, xylitol, pearlitol, beeswax, cetyl palmitate, glyceryl behenate, paraffin wax, and stearic alcohol.
- the glidants used are talcum and magnesium stearate.
- any other glident known to a person skilled in the art can be used.
- chewable tablets are made that are fortified with vitamin D3 and calcium carbonate by wet granulation.
- the tablets of this invention may contain Vitamin D3 essentially 100 IU to 400 IU, Calcium carbonate essentially 200 mg to 500 mg, a mixture of sweeteners and flavoring agents consisting essentially 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg Pharma grade sugar, 10.0 mg to 100.0 mg of flavoring agents, a pharmaceutically acceptable carrier, wherein the complete dosage unit, which resembles like a biscuit in shape, weighs around 5.50 g to 7.50 g.
- this invention comprises a method for manufacturing solid milk fortified with additional nutritional components and a method for manufacturing thereof.
- this invention comprises chewable tablets fortified with milk protein, folic acid and enteric release iron using moisture activated dry granulation process.
- Iron consisting essentially of 100 to 300 mg ferrous as ferrous sulphate
- Folic acid consisting essentially of folic acid 100 meg to 500 meg.
- a mixture of sweeteners and flavoring agents consisting essentially 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg Pharma grade sugar, 10.0 mg to 100.0 mg of flavoring agents, a pharmaceutically acceptable carrier, wherein the complete dosage unit weights 5.50 g to 7.50 g.
- In yet another embodiment of this invention comprises coating of iron which leads to improved patient compliance, with no gastric irritation, no vomiting and no need for extra antacids.
- this invention comprises chewable milk tablets fortified with trace minerals and vitamins using hot melt granulation.
- this invention comprises a granulated water insoluble milk powder formulation.
- impurity profile of vitamins and minerals is minimized in tablets/powder as the process is one pot.
- Moisture activated dry granulation process for example, is a "one pot" process, as all the steps involves during granulation are carried out in single pot. Avoiding use of multiple equipments for moisture activated dry granulation procedure lead to less chances of impurity, since impurity is generated where multiple steps and multiple equipments are involved.
- a mixture of vitamins consisting essentially of thaimine 1 to 4.5 mg, riboflavin 1 to 5 mg, Instagramnamide 10 to 40 mg, folic acid 100 meg to 500 meg, pyridoxine 1 mg to 3 mg, c y; nocobalamine 1 to 5 meg, vitamin C 30 mg to 80 mg, Vitamin D3 100 IU to 400 IU.
- a mixture of minerals consisting essentially of 100 to 200 mg of calcium as calcium carbonate, 2-10 mg of zinc as zinc sulpahte, 25 to 100 mg of magnesium as magnesium trisilicate.
- a mixture of sweeteners and flavoring agents consisting essentially 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg Pharma grade sugar, 10.0 mg to 100.0 mg of flavoring agents.
- a pharmaceutically acceptable carrier is selected from:
- Example 1 chewable compressed milk formulation using wet granulation process for milk powder
- the dry mixed blend was granulated with above prepared binder solution in the RMG for about 20 min. 5.
- the granules obtained from above process were dried in fluid bed dryer for 20 min.
- Flavor was added and mixing was done in blender for 5 minutes resulting into water insoluble granulated milk powder.
- Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets or chewable tablet.
- Example 2 chewable compressed milk formulation using Moisture
- Flavor was added and mixing was done in blender for 5 minutes resulting into water insoluble granulated milk powder.
- Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 mih. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
- Example 3 chewable compressed milk formulation using hot melt granulation process for milk powder.
- Example 4 chewable compressed milk formulation fortified with calcium carbonate (200 mg) and vitamin D3 (100 IU) by wet granulation
- the dry mixed blend was granulated with above prepared binder solution in the rapid mixture granulator for about 20 min. 5.
- the granules obtained from above process were dried in fluid bed dryer for 20 min.
- Flavor was added and mixing was done in blender for 5 minutes, resulting into water insoluble granulated milk powder.
- Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 0 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
- Example 5 chewable compressed milk formulation fortified with milk proteins, folic acid and enteric coated iron by Moisture Activated Dry Granulation process
- Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewabie tablets.
- Example 6 Chewabie compressed milk formulation fortified with vitamins, minerals by hot melt granulation process for milk powder
- Niacinamide 10.2 calcium carbonate (oyster shell) 1000
- Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises a solid dosage form of milk that is essentially substantially water insoluble in water and does not contain rice flour or any other staple food source that is used as food in daily diet by a human being or dried egg yolk powder. The invention also includes a process of making the said solid dosage form of milk. The solid dosage form of milk comprises milk powder and at least one binder; and may contain other ingredients. The solid dosage form of milk may be or an essentially water insoluble granulated milk powder when the milk powder composition with or without other ingredients is granulated and dried with a binder that essentially or substantially reduces the solubility of the milk powder in water upon granulation and drying. The granulated and dried milk powder, upon pressing, results into a chewable tablet or other chewable compressed formulation.
Description
TITLE
CHEWABLE MILK COMPOSITIONS AND FORTIFIED POWDER FORMULATIONS THEREOF.
TECHNICAL FIELD The invention relates to chewable milk compositions and method of making the same
BACKGROUND OF THE INVENTION
Milk has been considered as very important source of nutrition, since time immemorial. During the early years of growth milk constitutes the major part of diet. In many countries milk is supplied by government or nonprofit organization to school, so that health of the school children can be taken care of. But milk itself has many limitations that creates hurdle in its storage, supply and distribution. Milk has short shelf life hence its stability is poor. Milk requires significantly large storage space and refrigeration and thus it is often difficult to transport or store in its liquid form due to the weight and its highly perishable nature. The physical delivery of milk to schools, dairy and distributors requires stocking milk in refrigerators. And, schools are also required to have the provision for refrigerators/ chilled vending for storage of fresh milk. All these practices increase the cost of milk distribution.
Milk in liquid form that is supplied to nutrition intervention programs or applied nutrition programs is also very much prone for adulteration and its unauthorized clandestine diversion for unintended uses such as for drinking or for usual milk applications such as making tea, coffee, sweets, yogurts,
cheese etc. This pilferage or/and wastage/ or spoilage of liquid milk in a school feeding program is a great practical problem difficult to solve. Convenient distribution of liquid milk amongst the beneficiaries every day is also very difficult to manage. Unauthorized use mentioned above includes use for household purposes or for commercial purposes to make milk containing beverages like tea/coffee, or milk containing sweets etc.
Thus, liquid milk is prone for pilferage.
Further, being liquid, distribution of fixed dose of milk is cumbersome. Liquid milk is highly susceptible to microbial growth on storage. Milk contains most of the nutrients that are required for the growth of children but many children do not like taste of liquid milk. In case of liquid milk, continuous periodic testing and vigilance is required for maintaining its quality. This testing and vigilance require infrastructure which is difficult to maintain and create. Lack of testing and vigilance affect viability of distribution of liquid milk in Nutrition Intervention programs or applied Nutrition programs seriously.
It is very difficult to convert liquid milk and milk powder into a convenient and viable unit dosage form. Though the milk is good source of calcium, proteins and fats, it contains lower level of these nutrients and does not contain other essential nutrients like vitamin D3, iron etc. Fortified food preparations and essential nutrient supplements are in the market since a very long time. However, they have several shortcomings which need to be overcome. Milk is a food most suitable, the fortification of which will be useful to most of the population of India as well as world.
Mitsuho et al. (US 2009/0175998 A1) provided solid milk having suitable solubility and strength. This invention was based on the knowledge that solid milk with sufficient solubility and strength can be obtained basically by compacting and molding only powdered milk as an ingredient under a condition where porosity and free fat content thereof are controlled within fixed ranges and then humidifying and drying. This, however, needs to be reconstituted with water by weighing known quantity of solid milk and b adding water to it.
Mayurachat et al (2007) (Mayurachat Natvaratat, Penkwan chompreeda, Vichai Haruthaithanasan and Hathairat rimkeeree Kasetsart J. (Nat. Sci.), 41: 733-739, 2007) formulated milk tablet under Royal Chitralada Projects to encourage more dairy consumption for Thai children. In this project, milk tablets with high nutritive value were formulated for rural school children. The tablets were formulated to minimize cost and maximize protein and energy. These tablets, although they were called milk tablets, however, were a mixture of whole milk powder and dried egg yolk powder that contained 35% rice flour and sugar. The compressed product is consumed like any solid food products. Since these tablets contain nutrient sources other than milk, such as eggs and rice, these tables are not useful for a milk feeding program since their nutritive value will not be equivalent to milk feeding and these tablets cannot be a substitute for liquid milk in a Nutritional Intervention program.
Henry Secher Brochner (GB894001 A ) formulated milk tablets readily soluble in coffee and tea. It contained 10-19 %butter fat, 7-15% milk protein,
15-65% milk carbohydrates and minor amounts of inorganic milk constituents and water, and is enriched with respect to one or more of the butter fat, protein or carbohydrate. For compression of tablets condensed milk was evaporated to at least 6% of fat content to powder, and powder was mixed with milk proteins and lactose in requisite proportion. But being readily soluble in coffee and tea makes it pilferage prone and unsuitable for a Nutritional Intervention program since the product cannot be prevented from use for an unauthorized / un-intended purposes.
There are many fortified milk preparations available in the market that are in liquid form. Tablets have also been produced out of powdered milk. U.S. Pat. No. 3,241 ,975 and European Patent Application 1 048 216 describe dry powders or milk tablets but all of them are meant for dissolving in water for use and consumption. None of the prior art milk tablets or powders can prevent their use for purposes other than nutritional intervention programs in schools.
All prior art solid milk products that contain only milk as source of nutrients can be reconstituted to liquid milk or can be used to make traditional milk solids based sweets and, hence, they are also vulnerable to pilferage/unauthorized diversion for making milk based sweets, liquid milk or milk based beverages and unsuitable for a Nutrition Intervention program having an objective of providing milk to the children.
SUMMARY OF THE INVENTION
This invention comprises a solid dosage form of milk that is essentially substantially water insoluble in water and does not contain rice flour or any
other staple food source that is used as food in daily diet by a human being or dried egg yolk powder. The milk powder includes one or more of, without limitation, whole milk powder, partly skimmed milk powder, skimmed milk powder, and colostrum powder.
In one embodiment, the solid dosage form of milk comprises milk powder and at least one binder.
In another embodiment, the solid dosage form of milk of this invention further comprising other ingredients also. The other ingredients may comprise permitted food additives and permitted pharmaceutical ingredients and excipients.
In one embodiment, the solid dosage form of milk is a chewable tablet or other chewable compressed formulation. The chewable tablet of milk comprises a predetermined shape and size. The shape and size of the chewable tablet of milk is chosen such that the product is easy to handle during transportation and easier for distribution. The chewable tablet of milk may be biscuit shaped. The chewable tablet of milk conveniently weights 5.50 g to 7.50 g. The chewable tablet of milk powder may comprise an accurate desired dose of all the nutrients corresponding to a certain quantity of liquid whole milk or a milk powder.
In another embodiment, the solid dosage form of milk according to this invention comprises an essentially water insoluble granulated milk powder. In yet another embodiment, this invention comprises a process of making a solid dosage form of milk that is essentially substantially water insoluble in water and does not contain rice flour or dried egg yolk powder, or any other
staple food source that is used as food in daily diet by a human being, the process comprising steps of: (a) mixing the milk powder with at least one binder and optionally other ingredients; wherein the binder is such that upon binding, the solubility of milk powder in water decreases, (b) granulation, (c) drying and milling the granules, if required, (d) optionally adding flavor, and (e) either (i) packing the resulting an essentially water insoluble granulated milk powder in sachets, or (ii) adding glident s and pressing into chewable
)
tablets or a chewable compressed formulation.
The step of granulation is either wet granulation, hot melt granulation or moisture activated dry granulation.
In one embodiment the process of making a solid dosage form of milk of this invention results is an essentially water insoluble granulated milk powder when the final granulated powder resulting form the process is not pressed to result into a chewable tablet or other chewable compressed formulation. In another embodiment, the process of making a solid dosage form of milk of this invention results into a chewable tablet or other chewable compressed formulation when the final granulated powder is mixed with glidents and pressed.
DETAILED DESCRIPTION OF THE INVENTION
In view of the above problem that pilferage of conventional liquid milk or ny form of milk such as milk tablets or milk powders that can be dissolved in water to reconstitute into milk is difficult to be prevented in nutrition intervention programs since they can be unauthorizedly diverted to be used by unintended end users who can make tea, coffee or traditional food recipes
that require milk as one ingredient from the milk meant for beneficiaries of the nutrition intervention programs. First objective of this work is to make such dosage forms from milk powders which shall be solid, so that they are shelf stable, and substantially insoluble in water so that there is no incentive to divert them to food uses. Such solid forms of milk shall have solubility in water that is so less than whole milk powder or skim milk powder that they can be described as substantially or essentially water insoluble solid forms of milk. The wording "substantially" and "essentially" indicates that although a small portion of these solid forma may dissolve n water, most of the part remains insoluble and reconstitution of the same by diluting with water to milk is not possible. Further, such forms could be used to further enrich them with other nutrients that are needed to be provided to the beneficiaries of nutrition intervention programs. Further objective is to make their packing such that transportation and consumption is convenient and, if possible, nutrient content in the servings can be accurately controlled.
In one embodiment this invention comprises a solid unit dosage form of whole milk or skimmed milk, with or without fortification by one or more of essential nutrients, colors, flavors and excipients; wherein the solid unit dosage form cannot be re-constituted as liquid milk. The compositions of this invention differ from prior art in that they are formulated to be very close to the composition of whole milk or to the composition of whole milk supplemented with one or more of specific isolates of nutrients. Thus the compositions of this invention cannot have any staple food item such as rice flour or egg yolk or any such staple food items etc. as supplementing /
fortifying ingredients in order to avoid significant deviation from the composition of milk. For the purpose of this specification, "staple food", sometimes simply referred to as a "staple" is a food, as defined by the link http://en.wikipedia.org/wiki/Staple_food that is eaten routinely and in such quantities that it constitutes a dominant portion of a standard diet in a given population, supplying a large fraction of the needs for energy-rich materials and generally a significant proportion of the intake of other nutrients as well. Above link further explains that "Staple foods vary from place to place, but typically they are inexpensive or readily available foods that supply one or more of the three organic macronutrients needed for survival and health: carbohydrates, proteins, and fats." Still further, the link notes that "Most staple plant foods are derived either from cereals such as wheat, barley, rye, maize, or rice, or starchy tubers or root vegetables such as potatoes, yams, taro, and cassava. Other staple foods include pulses (dried legumes), sago (derived from the pith of the sago palm tree), and fruits such as breadfruit and plantains. Staple foods may also contain, depending on the region, sorghum, olive oil, coconut oil and sugar. Most staples are plant materials, but in some communities fishing is the primary source of nutrition."
The link http://www.thefreedictionary.com/staple gives several meanings of the word "Staple" of which the meaning most applicable in present context is: "A basic dietary item, such as flour, rice, or corn".
For removal of any doubt, the expression "Staple food" as is used here is intended to exclude nutrients or selective class of nutrients that are in the form of essentially pure isolated compositions made either chemically or from
their natural raw material sources. Thus, for example, whereas wheat flour or corn flour are included in the term "Staple food", wheat germ oil or corn oil, being nutrients isolated form their raw material, are excluded from the term "Staple food" and, being oils, would be considered as "nutrient". Similarly, an antioxidant extracted from its raw material in an isolate form, such as alpha- tocopherol, would be excluded form the term "Staple food" or "Staple" and would come in the category of "anti-oxidants" that can be added to the compositions of this invention.
The invention also comprises a method of making a solid unit dosage form of whole milk or skimmed milk, with or without fortification by one or more of essential nutrients, colours, flavors and excipients; wherein the solid unit dosage form cannot be re-constituted as liquid milk and none of the fortification ingredients are naturally grown and naturally available food items that are consumed traditionally/conventionally.
The "nutrients", for the purpose of this specification, are defined to comprise, without limitation, one or more of vitamins, minerals and anti-oxidants and probiotics. The probiotics that can be added includes, without limitation, the bacteria Lactobacillus sp. With the changing demographic profile we expect to have more share of elderly people in the population. This set of population has its own set of nutritional requirements. Addition of probiotic in the milk formulations will meet nutritional requirement of geriatric population and menopausal women.
In one aspect, the unit dosage form of milk of this invention lacks at least one organoleptic property of milk in such a way that the product or its diluted form
cannot be used for food applications for which liquid milk or condensed (boiled down or concentrated) milk or milk powder is used in the past. In such an embodiment of this invention, the unit dosage form of milk of this invention cannot be used for applications in which liquid milk or condensed milk or milk powder needs to be used for their organoleptic properties. Thus, the product of this invention cannot either (a) be reconstituted into liquid milk by dissolving in water for making tea, coffee, curd or for drinking, flavored milk or (b) be used for adding in sweets that need liquid milk, condensed milk or a milk powder as an ingredient; examples of such sweets include, without limitation, Indian recipes Pedha, Gulab Jamun, Barfi, Kala-kand, Ras-gulla etc.
In one embodiment, this invention comprises solid compressed dosage forms of milk. Most preferred form is tablets. The tablets may be biscuit shaped. However, the compressed form may be other than a tablet also.
In another embodiment, the solid dosage form of milk of this invention further comprises other ingredients also besides milk. The ether ingredients may comprise permitted food additives and permitted pharmaceutical ingredients and excipients. The food additives and permitted pharmaceutical ingredients and excipients may comprise, without limitation, one or more of nutrients, colours, flavors, pharmaceutically acceptable carriers, sweeteners, antioxidents, other excipients not mentioned here and ingredients. The pharmaceutically acceptable carrier may include, without limitation, one or more of lactose, mannitol, dicalcium phosphate, microcrystalline cellulose, dextrose, maltose and the like. Sweetener may comprise without limitation,
one or more of sucralose, aspartame, neotame, sodium saccharin, potassium acesulfame and sucrose. Nutrients may comprises, without limitation, one or more of vitamins proteins .minerals and probiotics and the like. Vitamins added to the composition of this invention may include, without limitation, one or more of thaimine, riboflavin, Nicinamide, folic acid, pyridoxine, cynocobalamine, vitamin C and Vitamin D and the like. The "Vitamin D" includes all of its different forms, including Vitamin D3. Minerals may include, without limitation, one or more of iron as ferrous sulfate, calcium as calcium carbonate, zinc as zinc sulpahte and magnesium as magnesium trisilicate and the like,
A recommended unit dose of the solid dosage form of milk of this invention may range from 5.5 gram to 7.5 gram.
The solid dosage form of milk according to this invention may have, per unit dose that weights 5.50 g to 7.50 g: (a) vitamins added to it, essentially comprising thaimine 1 to 4.5 mg, riboflavin 1 to 5 mg, Nicinamide 1 to 40 mg, folic acid 100 meg to 500 meg, pyridoxine 1 mg to 3 mg, cynocobalamine 1 to 5 meg, vitamin C 30 mg to 80 mg, Vitamin D3 100 IU to 400 IU; (b) minerals added to it essentially comprising 10 to 200 mg of calcium as calcium carbonate, 2- to 10 mg of zinc as zinc sulpahte and 25 to 100 mg of magnesium as magnesium trisilicate, 5 to 525 mg of ferrous sulfate, (c) sweeteners added to it essentially comprising essentially of 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg of sugar, 1.0 mg to 50.0 mg of aspartame, 0.5 mg to 5 mg of neotame, 1.0 mg to 100.0 mg of sodium saccharin, and 1.0 mg to 100.0 mg of potassium acesulfame and (d)
flavoring agents added to it essentially comprising of 0.1.0 mg to 10.0 mg of the flavoring agents.
The solid dosage form of milk may contain supplement of (a) the mineral in the form of enteric release iron, (b) one or more of the vitamin selected from the group consisting of folic acid and Vitamin D3, and (c) the protein as milk protein.
Thus, an illustrative chewable tablet of milk may comprise Iron consisting essentially of 5 to 575 mg ferrous as ferrous sulphate, 100 meg to 500 meg of Folic acid, 1 mg to 100 mg of sweetener, 0.1.0 mg to 10.0 mg of flavoring agents and a pharmaceutically acceptable carrier, wherein the complete dosage unit weighting 5.50 g to 7.50 g.
Another illustrative chewable tablet of milk according to this invention may comprise Vitamin D3 essentially 100 IU to 400 IU, Calcium carbonate essentially 10 mg to 200 mg, sweetener 1.0 mg to 100.0, and flavoring agents 0.11 to 10 mg and weighing round 5.50 g to 7.50 g.
The chewable tablet of milk according to this invention may comprise the sweetener 1.0 mg to 10.0 mg of sucralose and/or 10.0 mg to 100.0 mg sugar,
In one embodiment, this invention comprises a chewable milk tablet or an essentially water insoluble milk powder, that does not reconstitute into liquid milk on adding water to the same.
In another embodiment of this invention, the chewable milk tablet is made in predetermined shape and size. The shape and size is chosen such that the
product is easy to handle during transportation and hence easier for distribution and does not have the disadvantage of large storage space and refrigeration required for use of liquid milk for nutritional intervention programs.
In another embodiment, the chewable milk tablet is made to provide an accurate desired dose of all the nutrients corresponding to a certain quantity of liquid milk or a milk powder.
In a further embodiment, the chewable milk tablet or the water insoluble milk powder is fortified with essential nutrients that can be added in an accurate and desired quantity in each tablet. The said essential nutrients may, without limitation, be one or more of vitamins, minerals. This will overcome the need of additional vitamins and minerals supplements that are usually required to be given separately to the beneficiaries of Applied Nutrition Programs such as for school children, women and elderly population.
Throughout this specification, the terms "Nutrition Intervention Programs" or "Applied Nutrition Programs" shall be used interchangeably, which are usually Government run or an Institution-run programs undertaken to supplement a vulnerable population with nutrient found deficient in the consumption of such population leading to development of health related problems/disorders/diseases.
In one aspect of a method of making a solid unit dosage form of whole milk or skimmed milk of this invention comprises granulation for developing solid compressed milk formulation without the use of water or with use of a
quantity of water that does not give a scope for microbial growth in the dosage form.
In another aspect, milk based formulations of this invention are made with the use of different colors and flavors to make them children friendly.
This invention comprises a milk based formulation with standardized composition prepared on large scale that cannot be adulterated and requires no further analysis at various locations once produced and packaged. Invention is also embodied wherein the compressed milk tablets are fortified with probiotics that offer several health benefits.
In present invention, the term milk powder means and includes any one selected from the group of whole milk powder, skimmed milk powder, partly skimmed milk powder or colostrum powder. Perishability of milk was overcome by using solid milk powder instead of liquid milk, thus resulting in chewable milk tablets with greater shelf life. The present invention also comprises a unique composition of chewable milk tablets and method of manufacturing thereof.
In present invention, attempt has been made to compress milk powder with sufficient hardness and also easily chewable.
In one embodiment, the essentially sunstantial reduction of the milk powder in water is achieved by use of binders, the binder being a food additive that shall bind the particles of the milk powder composition together when bound with ingredients of the milk powder and shall essentially retard or prevent solubilization/dissolution of the components held by it when contacted with water. The binder comprises, one or more, without limitation, povidone,
starch, maltodextrin, polyvinyl alcohol, xanthan gum, Sugar esters, gelucire, polyethylene glycols, stearic acid, cetyl alcohol, carnauba wax, paraffin wax, cetostearyl alcohol, hydrogenated castor oil, gyceryl monostearate, xylitol, pearlitol, beeswax, cetyl palmitate, glyceryl behenate, and the like. this invention comprises use of wet granulation for making milk tablets. It is also another embodiment of this invention wherein Hot Melt Granulation is used for making milk tablets. It is still another embodiment of this invention wherein Moisture Activated Dry Granulation (MADG) is used to make milk tablets.
In MADG, moisture is used to activate granule formation, without the need to apply heat to dry the granules. During this process, the generation of moist agglomerates is followed by the stepwise addition and blending of common pharmaceutical ingredients that absorb and distribute the moisture, which results in a uniform, free-flowing and compactable granulation. The said common pharmaceutical ingredients comprise one or more selected from a group consisting Microcrystalline cellulose, avicel PH 200 LM, Aeroperl 300, crospovidone, Avicel PH 101 , PH102, Aerosil, spress B. In another embodiment, this invention comprises a process of manufacturing of the compressed milk wherein in the drying process and sifting is avoided by using moisture activated/aided dry granulation process.
Following are the generalized advantages of MADG and Hot Melt Granulation
Advantages of wet granulation:
• Improving uniformity, flow and compactaility of granules.
Advantages of MADG over conventional granulation/ wet granulation process
• The MADG method produces granules with excellent flow-ability.
· The tablets prepared using the MADG method have better content uniformity.
• MADG is a simple, economical, clean, lean and robust process that creates granulation with very good physical properties and finished products with satisfactory quality attributes. In the MADG process, only a small amount of water is used to create agglomeration. Moisture distribution and absorption steps follow, and neither heat drying nor milling is needed.
In Hot Melt Granulation, drying step can be avoided, and hence it is time saving, cost effective and economic process.
In yet another aspect this invention, solid milk chewable tablets are provided without any addition of external moisture and method of manufacturing thereof. In this embodiment, the method of manufacture uses Hot Melt Granulation process. In this embodiment, this was achieved by using binders that melt at higher temperature and bring about granulation upon cooling. The hot melt binders that can be used in present invention include, without limitation, one or more of or a mixture of one or more of polyethylene glycol 6000, polyethylene glycol 4000, carnauba wax, stearic acid, sugar esters, cetostearyl alcohol, hydrogenated castor oil, gelucire 55/18, gelucire 50/02,
glyceryl monostearate, xylitol, pearlitol, beeswax, cetyl palmitate, glyceryl behenate, paraffin wax, and stearic alcohol.
For making tablets form the granulated mix, in the illustrative examples, the glidants used are talcum and magnesium stearate. However, any other glident known to a person skilled in the art can be used.
In a further aspect of this invention, chewable tablets are made that are fortified with vitamin D3 and calcium carbonate by wet granulation. The tablets of this invention may contain Vitamin D3 essentially 100 IU to 400 IU, Calcium carbonate essentially 200 mg to 500 mg, a mixture of sweeteners and flavoring agents consisting essentially 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg Pharma grade sugar, 10.0 mg to 100.0 mg of flavoring agents, a pharmaceutically acceptable carrier, wherein the complete dosage unit, which resembles like a biscuit in shape, weighs around 5.50 g to 7.50 g. In a further embodiment, this invention comprises a method for manufacturing solid milk fortified with additional nutritional components and a method for manufacturing thereof.
In yet another embodiment, this invention comprises chewable tablets fortified with milk protein, folic acid and enteric release iron using moisture activated dry granulation process. Iron consisting essentially of 100 to 300 mg ferrous as ferrous sulphate, Folic acid consisting essentially of folic acid 100 meg to 500 meg. A mixture of sweeteners and flavoring agents consisting essentially 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg Pharma grade sugar, 10.0 mg to 100.0 mg of flavoring agents, a
pharmaceutically acceptable carrier, wherein the complete dosage unit weights 5.50 g to 7.50 g.
In yet another embodiment of this invention comprises coating of iron which leads to improved patient compliance, with no gastric irritation, no vomiting and no need for extra antacids.
In yet another embodiment, this invention comprises chewable milk tablets fortified with trace minerals and vitamins using hot melt granulation.
In yet another embodiment, this invention comprises a granulated water insoluble milk powder formulation.
In yet another embodiment of this invention impurity profile of vitamins and minerals is minimized in tablets/powder as the process is one pot. Moisture activated dry granulation process, for example, is a "one pot" process, as all the steps involves during granulation are carried out in single pot. Avoiding use of multiple equipments for moisture activated dry granulation procedure lead to less chances of impurity, since impurity is generated where multiple steps and multiple equipments are involved.
The ranges of amounts of ingredients given herein below relate to the amount of said ingredients in the compositions of this invention and include appropriate overages:
1. Weight of complete dosage unit: 5.50 g to 7.50 g,
2. A mixture of vitamins consisting essentially of thaimine 1 to 4.5 mg, riboflavin 1 to 5 mg, Nicinamide 10 to 40 mg, folic acid 100 meg to 500 meg, pyridoxine 1 mg to 3 mg, c y; nocobalamine 1 to
5 meg, vitamin C 30 mg to 80 mg, Vitamin D3 100 IU to 400 IU.
A mixture of minerals consisting essentially of 100 to 200 mg of calcium as calcium carbonate, 2-10 mg of zinc as zinc sulpahte, 25 to 100 mg of magnesium as magnesium trisilicate. A mixture of sweeteners and flavoring agents consisting essentially 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg Pharma grade sugar, 10.0 mg to 100.0 mg of flavoring agents.
A pharmaceutically acceptable carrier.
The invention is illustrated by following examples which are merely illustrative of the invention without limiting it in any manner. Unless the context does not permit, a singular also includes the pleural, for example, a polymer also includes "polymers" and all equivalents and variants obvious to a person skilled in the art are considered to be included in this disclosure.
Example 1: chewable compressed milk formulation using wet granulation process for milk powder
Following ingredients are used to make a chewable milk tablet
Process:
1. First milk powder, sucralose, erythrosine color and pharma Grade sugar was sifted through mesh #40.
2. Then, the above sifted blend was transferred to the RMG (Rapid Mixer Granulator) for dry mixing for about 20 minutes at 3 rpm (revolutions per minute).
3. Distilled water was boiled on heating pan and then xanthan gum was dissolved with continuous stirring to obtain uniform dispersion and then PG (Phrma grade) sugar was added.
4. The dry mixed blend was granulated with above prepared binder solution in the RMG for about 20 min.
5. The granules obtained from above process were dried in fluid bed dryer for 20 min.
6. Milling of the above obtained granules was done and sifted through • #25.
7. Flavor was added and mixing was done in blender for 5 minutes resulting into water insoluble granulated milk powder.
8. Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets or chewable tablet.
Example 2: chewable compressed milk formulation using Moisture
Activated Dry Granulation process for milk powder.
1. Firstly milk powder, sucralose, erythrosine color and pharma grade sugar was sifted through mesh #40.
2. Then, the above sifted blend was transferred to the RMG for dry mixing for about 20 minutes at 3 rpm.
3. During mixing, 2% water was sprayed onto the powder blend, thus moistening the binder Povidone and making it tacky.
4. Flavor was added and mixing was done in blender for 5 minutes resulting into water insoluble granulated milk powder.
9. Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 mih. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
Example 3: chewable compressed milk formulation using hot melt granulation process for milk powder.
1. Firstly milk powder, sucralose, meltable binder (Sugar esters/PEG 6000) and PG sugar was sifted through Mesh #40.
2. Then, the above sifted blend was transferred to the jacketed planetary mixer, missing was done for about 20 minutes at 3 rpm.
3. Planetary mixer was heated at 80°C for 30 min.
4. The granules were cooled at room temperature. After cooling, milling was done and granules were sifted through mesh #25.
5. Flavor was added and mixing was done in planetary mixer for 5 minutes resulting into water insoluble granulated milk powder.
10. Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 0 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
Example 4: chewable compressed milk formulation fortified with calcium carbonate (200 mg) and vitamin D3 (100 IU) by wet granulation
1. Firstly milk powder, calcium carbonate, sucralose, erythrosine color and pharma grade sugar was sifted through mesh #40.
2. Then, the above sifted blend was transferred to the Rapid Mixer Granulator for dry mixing for about 20 minutes at 3 rpm.
3. Distilled water was boiled on heating pan and then xanthan gum was dissolved with continuous stirring to obtain uniform dispersion and then pharma grade sugar was added.
4. The dry mixed blend was granulated with above prepared binder solution in the rapid mixture granulator for about 20 min.
5. The granules obtained from above process were dried in fluid bed dryer for 20 min.
6. Milling of the above obtained granules was done and sifted through #25.
7. Flavor was added and mixing was done in blender for 5 minutes, resulting into water insoluble granulated milk powder.
11. Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 0 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
Example 5: chewable compressed milk formulation fortified with milk proteins, folic acid and enteric coated iron by Moisture Activated Dry Granulation process
Excipients Quantity used
Dried Ferrous Sulphate 150
Povidone
Neutral pellets 100
•Cetyl alcohol 2
Acrycoat UOO 30
Diethyl phthalate 100
Milk powder 5000
Sucralose 7
Pharma grade sugar 183
Folic Acid 5
Flavoring agent 114
Magnesium stearate 2
Talcum 4
Process:
1. Firstly milk powder, sucralose and pharma grade sugar was sifted through mesh #40.
2. Then, the above sifted blend was transferred to the rapid mixture granu!ator for dry mixing for about 20 minutes at 3 rpm.
3. During mixing, 2% water was sprayed onto the powder blend, thus moistening the binder povidone and making it tacky.
4. Dried ferrous sulphate was coated on to neutral pellets using powder layering technique and was mixed with above blend.
5. Flavor was added and mixing was done in blender for 5 minutes resulting into water insoluble granulated milk powder.
12. Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewabie tablets.
Example 6: Chewabie compressed milk formulation fortified with vitamins, minerals by hot melt granulation process for milk powder
Magnesium trisilicate 66.75
Folic acid 0.12 vitamin D3 5
Pyridoxine HCI 1
Vitamin C 31.5
Zinc sulphate 5.75
1. Firstly milk powder, sucralose, meltable binder (Sugar esters/PEG 6000), erythrosine color and pharma grade sugar was sifted through mesh #40.
2. Then, the above sifted blend was transferred to the jacketed planetary mixer for dry mixing for about 20 minutes at 3 rpm.
3. Planetary mixer was heated at 80°C.
4. The granules were cooled at room temperature. After cooling milling was done and sifted through #25. Flavor, vitamins and minerals as mentioned in the table was added and mixing was done in blender for 10 minutes resulting into water insoluble granulated milk powder.
13. Either the resulting water insoluble granulated milk powder was (a) packed in small packing or bulk packing or (b)talcum and magnesium stearate were added to the same, mixed for 10 min. and compression of the resulting blend was done by using 35 mm, circular, flat, D tooling punches to result into chewable tablets.
Claims
1. A solid dosage form , of milk that is essentially substantially water insoluble in water and does not contain rice flour or any other staple food source that is used as food in daily diet by a human being or dried egg yolk powder,.
2. The solid dosage form of milk according to claim 1 wherein the milk powder comprises one or more selected from the group essentially consisting of whole milk powder, partly skimmed milk powder, skimmed milk powder, and colostrum powder.
3. The solid dosage form of milk according to claim 2 comprising milk powder and at least one binder; the binder being a food additive that shall bind the particles of the milk powder composition together when bound with ingredients of the milk powder and shall essentially retard or prevent solubilization/dissolution of the components held by it when contacted with water.
4. The solid dosage form of milk according to claim 3 wherein the binder is selected from one or more from a group consisting essentially of povidone, starch, maltodextrin, polyvinyl alcohol, xanthan gum Sugar esters, gelucire, polyethylene glycols, stearic acid cetyl alcohol, carnauba wax, paraffin wax, cetostearyl alcohol, hydrogenated castor oil, gyceryl monostearate, xylitol, pearlitol, beeswax, cetyl palmitate and glyceryl behenate.
5. The solid dosage form of milk according to claim 4 further comprising other ingredients. .
6. The solid dosage form of milk according to claim 5; wherein the other ingredients comprise one or more selected form the group essentially consisting of nutrients, colours, flavors, pharmaceutically acceptable carrier, sweetener and other excipients.
7. The solid dosage form of milk according to claim 6, wherein:
a. pharmaceutically acceptable carrier comprises one or more selected form the group consisting essentially of lactose, mannitol, dicalcium phosphate, microcrystalline cellulose, dextrose, maltose,
b. Sweetener comprises- one or more selected from the group consisting essentially of sucralose, aspartame, neotame, sodium saccharin, potassium acesulfame and sucrose. c. nutrient comprises one or more selected from the group consisting essentially of vitamins proteins .minerals and probiotics.
8. The solid dosage form of milk according to claim 7 wherein:
a. vitamins are selected one or more from the group consisting essentially of thaimine, riboflavin, Nicinamide, folic acid, pyridoxine, cynocobalamine, vitamin C and Vitamin D. b. minerals are selected one or more from the group consisting essentially of iron as ferrous sulfate, calcium as calcium carbonate, zinc as zinc sulpahte and magnesium as magnesium trisilicate,
9. The solid dosage form of milk according to claim 8 wherein, per unit dose of 5.50 g to 7.50 g:
a. the range in which the vitamins are added comprises, essentially of, thaimine 1 to 4.5 mg, riboflavin 1 to 5 mg, Nicinamide 1 to 40 mg, folic acid 100 meg to 500 meg, pyridoxine 1 mg to 3 mg, cynocobalamine 1 to 5 meg, vitamin C 30 mg to 80 mg, Vitamin D3 100 IU to 400 III,
b. the range in which the minerals are added comprises, essentially of, 0 to 200 mg of calcium as calcium carbonate, 2- to 10 mg of zinc as zinc sulpahte and 25 to 100 mg of magnesium as magnesium trisilicate, 5 to 525 mg of. ferrous sulfate.
c. the range in which the sweeteners are used comprises, essentially of 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg of sugar, 1.0 mg to 50.0 mg of aspartame, 0.5 mg to 5 mg of neotame, 1.0 mg to 100.0 mg of sodium saccharin, and 1.0 mg to 100.0 mg of potassium acesulfame,
d. the range in which the flavoring agents are used comprises, essentially of 0.1.0 mg to 10.0 mg of the flavoring agents.
10. The solid dosage form of milk according to claim 7, wherein: (a) the mineral is enteric release iron, (b) one or more of the vitamin is selected from the group consisting of folic acid and Vitamin D3, and (c) the protein is milk protein.
11. The solid dosage form of milk according to claim 3, wherein the dosage form is a chewable tablet or other chewable compressed formulation.
12. The chewable tablet of milk according to claim 11 , that comprises a predetermined shape and size.
3. The chewable tablet of milk according to claim 12, wherein the shape and size of the tablet is chosen such that the product is easy to handle during transportation and easier for distribution.
14. The chewable tablet of milk according to claim 13; wherein the tablet is biscuit shaped.
15. The chewable tablet of milk according to claim 12; wherein the complete dosage unit weights 5.50 g to 7.50 g.
16. The chewable tablet of milk or milk powder according to claim 11 ; wherein the chewable milk tablet comprises an accurate desired dose of all the nutrients corresponding to a certain quantity of liquid whole milk or a milk powder.
17. The chewable tablet of milk according to claim 11 comprising Iron consisting essentially of 5 to 575 mg ferrous as ferrous sulphate, 100 meg to 500 meg of Folic acid, 1 mg to 100 mg of sweetener, 0.1.0 mg to 10.0 mg of flavoring agents and a pharmaceutically acceptable carrier, wherein the complete dosage unit weighting 5.50 g to 7.50 g.
18. The chewable tablet of milk according to claim 11 comprising Vitamin D3 essentially 00 I U to 400 IU, Calcium carbonate essentially 10 mg
to 200 mg, sweetener 1.0 mg to 100.0, and flavoring agents 0.11 to 10 mg and weighing round 5.50 g to 7.50 g.
19. The chewable tablet of milk according to claim 11 wherein the sweetener comprises 1.0 mg to 10.0 mg of sucralose, 10.0 mg to 100.0 mg sugar,
20. The solid dosage form of milk according to claim 3, wherein the dosage form is an essentially water insoluble granulated milk powder.
21. A process of making a solid dosage form of milk that is essentially substantially water insoluble in water and does not contain rice flour or dried egg yolk powder, or any other staple food source that is used as food in daily diet by a human being, the process comprising steps of: a. mixing the milk powder with at least one binder and optionally other ingredients; wherein the binder is such that upon binding, the solubility of milk powder in water decreases,
b. granulation,
c. drying and milling the granules, if required,
d. optionally adding flavor, and
e. either (i) packing the resulting water insoluble powder, or (ii) adding glident/s and pressing into tablets.
22. The process of making a solid dosage form of milk of claim 21 wherein:
a. the binder is selected one or more from the group essentially consisting of povidone, starch, maltodextrin, polyvinyl alcohol, xanthan gum, Sugar esters, gelucire, polyethylene glycols,
stearic acid, cetyle alcohol, carnauba wax, paraffin wax, cetostearyl alcohol, hydrogenated castor oil, gyceryl monostearate, xylitol, pearlitol, beeswax, cetyl palmitate, and glyceryl behenate.
b. other ingredients may comprise one or more selected from the group essentially consisting of nutrients, anti-oxidents, surfactants, colours, pharmaceutically acceptable carrier, sweetener, probiotics, pharmaceutically active ingredient and other excipients,
c. glidants comprise talcum and magnesium stearate.
23. The process of making a solid dosage form of milk of claim 21 , wherein the step of granulation is either wet granulation, hot melt granulation or moisture activated dry granulation.
24. The process of making a solid dosage form of milk of claim 22 wherein the solid dosage form is an essentially water insoluble granulated milk powder.
25. The process of making a solid dosage form of milk of claim 22 wherein the solid dosage form is a a chewable tablet or other chewable compressed formulation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3418MU2012 | 2012-12-03 | ||
IN3418/MUM/2012 | 2012-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014087422A1 true WO2014087422A1 (en) | 2014-06-12 |
Family
ID=50882899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2013/000737 WO2014087422A1 (en) | 2012-12-03 | 2013-12-02 | Chewable milk compositions and fortified powder formulations thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014087422A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108719476A (en) * | 2017-04-21 | 2018-11-02 | 内蒙古乳业技术研究院有限责任公司 | Application of the dry granulation process in the preparation of milk tablet |
CN110432330A (en) * | 2019-08-01 | 2019-11-12 | 北京工商大学 | A kind of health type skimmed milk chewable tablets and preparation method thereof |
US11102998B1 (en) | 2017-08-25 | 2021-08-31 | The Hershey Company | Binders and methods of making and using the same |
CN113558106A (en) * | 2021-07-30 | 2021-10-29 | 内蒙古利诚实业有限公司 | Granulation method of milk tablet product with high milk powder and high protein content |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004095946A2 (en) * | 2003-04-24 | 2004-11-11 | Abbott Laboratories | Medical food tablets containing free amino acids |
US20080008742A1 (en) * | 2006-06-29 | 2008-01-10 | Capricorn Pharma, Inc. | Chewy products and methods for making the same |
US7998505B2 (en) * | 2006-10-27 | 2011-08-16 | Fmc Corporation | Dry granulation binders, products, and use thereof |
US20120035277A1 (en) * | 2010-08-04 | 2012-02-09 | Hero Nutritionals, LLC | Liquid-filled chewable supplement |
WO2012080469A1 (en) * | 2010-12-16 | 2012-06-21 | Nestec S.A. | Soluble milk-based tablet surface-treated with carbohydrate |
-
2013
- 2013-12-02 WO PCT/IN2013/000737 patent/WO2014087422A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004095946A2 (en) * | 2003-04-24 | 2004-11-11 | Abbott Laboratories | Medical food tablets containing free amino acids |
US20080008742A1 (en) * | 2006-06-29 | 2008-01-10 | Capricorn Pharma, Inc. | Chewy products and methods for making the same |
US7998505B2 (en) * | 2006-10-27 | 2011-08-16 | Fmc Corporation | Dry granulation binders, products, and use thereof |
US20120035277A1 (en) * | 2010-08-04 | 2012-02-09 | Hero Nutritionals, LLC | Liquid-filled chewable supplement |
WO2012080469A1 (en) * | 2010-12-16 | 2012-06-21 | Nestec S.A. | Soluble milk-based tablet surface-treated with carbohydrate |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108719476A (en) * | 2017-04-21 | 2018-11-02 | 内蒙古乳业技术研究院有限责任公司 | Application of the dry granulation process in the preparation of milk tablet |
US11102998B1 (en) | 2017-08-25 | 2021-08-31 | The Hershey Company | Binders and methods of making and using the same |
CN110432330A (en) * | 2019-08-01 | 2019-11-12 | 北京工商大学 | A kind of health type skimmed milk chewable tablets and preparation method thereof |
CN113558106A (en) * | 2021-07-30 | 2021-10-29 | 内蒙古利诚实业有限公司 | Granulation method of milk tablet product with high milk powder and high protein content |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109170472A (en) | Direct drinking type acerola concentrate solid beverage | |
JP2017225453A (en) | Powdered nutritional formulations including spray-dried plant protein | |
MX2012008778A (en) | Nutritional powders comprising spray dried hmb. | |
CN103989174A (en) | Moringa oleifera composite all-nutrition nutrient | |
WO2014087422A1 (en) | Chewable milk compositions and fortified powder formulations thereof | |
CN103271166A (en) | Soybean whey composite powder and preparation method thereof | |
US6716466B2 (en) | Balanced food powder composition | |
CN101594790A (en) | The novel use of (-)-Epigallo-catechin gallate (EGCG) | |
CN108697679A (en) | Composition containing amino acid | |
KR20170100279A (en) | Method for manufacturing brown rice cereal | |
CN102228447B (en) | Zinc-selenium chewable tablet | |
US20120288573A1 (en) | Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders | |
CN114586850A (en) | Milk-containing solid molded product containing cheese and preparation method thereof | |
CN104921017B (en) | A kind of instant purple sweet potato milk powder breakfast porridge and its production technology | |
CN105285315A (en) | Muslim yak milk casein phosphopeptide nutrition powder | |
CN110651940A (en) | Marine fishbone collagen oligopeptide powder solid beverage and preparation method thereof | |
JP4588403B2 (en) | Method for producing calcium / magnesium-containing composition | |
CN102048119B (en) | Low-calorie nutritional compound sucrose | |
RU2660263C1 (en) | Caramel with filling of functional purpose with hypolipidemic properties to improve memory processes | |
RU2202217C2 (en) | Composition for dragee production | |
RO133075A0 (en) | Method for preparing and characterizing orodispersible egg powder | |
US20220232846A1 (en) | Methods of Using Acid Whey | |
Kumkum et al. | Chemical, functional and nutritional characteristics of weaning food formulations | |
DE102005050879A1 (en) | Use of powdered mixtures or vegetable or animal protein mixture (obtained by quellung) as food additives for applying in finished or in the preparation of food and/or beverages | |
CN102919363A (en) | Health-care food and preparation process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13861202 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13861202 Country of ref document: EP Kind code of ref document: A1 |